Use of germline polymorphisms in predicting concurrent chemoradiotherapy response in esophageal cancer. [electronic resource]
Producer: 20120511Description: 1996-2003 p. digitalISSN:- 1879-355X
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Chemoradiotherapy -- methods
- Chromosomes, Human, Pair 2 -- genetics
- Cisplatin -- administration & dosage
- Disease Progression
- Esophageal Neoplasms -- genetics
- Esophagectomy
- Fluorouracil -- administration & dosage
- Genome-Wide Association Study -- methods
- Humans
- Linkage Disequilibrium -- genetics
- Male
- Middle Aged
- Models, Genetic
- Polymorphism, Single Nucleotide
- Prospective Studies
- Radiotherapy Dosage
- Remission Induction -- methods
- Taiwan
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.